Deka Bank Deutsche Girozentrale Burning Rock Biotech LTD Transaction History

Deka Bank Deutsche Girozentrale

  • $53.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 02, 2022
SELL
$9.43 - $17.14 $24,989 - $45,421
-2,650 Closed
0 $0
Q3 2021

Oct 22, 2021
SELL
$17.37 - $27.92 $3,196 - $5,137
-184 Reduced 6.49%
2,650 $428,000
Q2 2021

Aug 05, 2021
BUY
$26.14 - $37.45 $74,080 - $106,133
2,834 New
2,834 $772,000

Others Institutions Holding BNR

# of Institutions
1
Shares Held
21.2K
Call Options Held
0
Put Options Held
0
View Full List

About Burning Rock Biotech Ltd

BNR Quotes by TradingView
  • Ticker BNR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 105,188,000
  • Market Cap $446M
  • Description
  • Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...
More about BNR
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email